Appili Therapeutics Inc. (TSXV: APLI.H)
Health Care · Pharmaceuticals · CA
CA$0.01
0.00% today · -75.0% 1Y
Appili Therapeutics Inc. (TSXV: APLI.H) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $464.39K and employs 7 people.
Over the last twelve months the share price has lost 75.0%, trading between 0.01 and 0.03.
Tweenvest scores Appili Therapeutics Inc. across four factors: quality 8/100, value 73/100. Its strongest factor is value.
APLI.H price history
Key figures
- Market cap
- $464.39K
- Revenue (TTM)
- $198.12K
- P/E
- -0.12
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- -0.02
- 52-week high
- CA$0.03
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 132.37M
- Employees
- 7
- Next earnings
- —
About Appili Therapeutics Inc.
Appili Therapeutics, Inc. is a biopharmaceutical company, which engages in acquisition and development of novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as LIKMEZ, ATI-1701 and ATI-1801. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
- ISIN
- CA03783R1073
- Founded
- 2015
- Listed since
- Jun 25, 2019
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Ovation Science Inc.CNSX: OVAT | $550.24K | CA$0.02 | -33.33% |
| Access-Power & Co., Inc.OTCPK: ACCR | $541.80K | $0.00 | -5.06% |
| Aequus Pharmaceuticals Inc.TSXV: AQS | $478.54K | CA$0.01 | 0.00% |
| Pharmadrug Inc.CNSX: PHRX | $470.87K | CA$0.01 | 0.00% |
| Fabino Enterprises LimitedBSE: 543444 | $453.32K | Rs20.31 | +4.96% |
| MPS Pharmaa LimitedBSE: 531686 | $417.82K | Rs2.08 | 0.00% |
| Altamira Therapeutics Ltd.OTCPK: CYTO.F | $404.66K | $0.07 | 0.00% |
| LiveCare, Inc.OTCPK: LVCE | $357.22K | $0.01 | 0.00% |